The maker of a pregnancy medication takes action against the federal agency for not stopping pharmacies from making and selling cheaper versions of the drug.
The Scientist
Most Recent
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
Legislation proposes speeding certain drug applications submitted to the US Food and Drug Administration.
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
